Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice.
Selenium modifies inflammatory reactions in rodents and humans. The liver controls metabolism and transport of selenium via hepatically-derived SEPP (selenoprotein P). Intracellular SEPS (selenoprotein S) modifies endoplasmic-reticulum function and immune-cell activity. Polymorphisms in SEPS have been associated with cytokine levels and inflammatory diseases in a subset of clinical studies. In the present study, we hypothesized that sex and selenium represent decisive parameters controlling the immune response and regulation of SEPS expression in vivo. Male and female mice fed a selenium-poor diet were supplemented or not with selenite for 3 days and injected with saline or LPS (lipopolysaccharide) 24 h before analysis. Selenium supplementation mitigated the LPS-induced rise in circulating cytokines in male mice. Serum SepP and selenium concentrations decreased in response to LPS, whereas hepatic SepS was specifically up-regulated despite declining selenium concentrations in the liver. Hepatic SepS induction was mainly controlled by post-transcriptional mechanisms and attributed to hepatocytes by analysing transgenic mice. Notably, selenium supplementation was essential for an optimal SepS induction. We conclude that selenoprotein biosynthesis becomes redirected in hepatocytes during the acute-phase response at the expense of dispensable selenoproteins (e.g. SepP) and in favour of SepS expression, thereby causing declining serum selenium and improving liver function. The selenium status and sex control SepS expression and modify cytokine response patterns in serum, which might explain contradictory results on associations of SEPS genotype and inflammatory diseases in clinical studies.
Stoedter
Mette
M
Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Südring 10, D-13353 Berlin, Germany.
Renko
Kostja
K
Hög
Antonia
A
Schomburg
Lutz
L
D000210:Acute-Phase Reaction / Q000276:immunology / Q000378:metabolism* / Q000503:physiopathology; D000595:Amino Acid Sequence; D000818:Animals; D045744:Cell Line, Tumor; D005260:Female; D005786:Gene Expression Regulation / Q000276:immunology; D008297:Male; D008565:Membrane Proteins / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D012643:Selenium / Q000008:administration & dosage* / Q000172:deficiency; D051149:Selenoprotein P / Q000096:biosynthesis* / Q000235:genetics; D051140:Selenoproteins / Q000096:biosynthesis* / Q000235:genetics; D012727:Sex Characteristics
D008565:Membrane Proteins; C487710:SELENOS protein, human; D051149:Selenoprotein P; D051140:Selenoproteins; D012643:Selenium